| Literature DB >> 34277973 |
Hannah Regeer1, Emma A Nieuwenhuijse2, Rimke C Vos2, Jessica C Kiefte-de Jong2, Pepijn van Empelen3, Eelco J P de Koning1, Henk J G Bilo4,5,6, Sasja D Huisman1.
Abstract
Aims: To investigate changes in physical activity (PA) and psychological factors during societal lockdown in people with type 2 diabetes.Entities:
Keywords: COVID‐19; physical activity behaviour; stress; type 2 diabetes
Mesh:
Year: 2021 PMID: 34277973 PMCID: PMC8279615 DOI: 10.1002/edm2.249
Source DB: PubMed Journal: Endocrinol Diabetes Metab ISSN: 2398-9238
FIGURE 1Flow‐chart participant inclusion
Population characteristics of total and per change in PA group in people with type 2 diabetes during COVID‐19 societal lockdown
|
Total ( |
No change in PA ( |
Less active ( |
More active ( | |
|---|---|---|---|---|
| Age, years (mean, SD) | 65.9 (7.9) | 67.5 (7.1) | 65.6 (8.1) | 63.4 (8.3) |
| Sex, men, | 290 (54.1) | 158 (62.7) | 65 (47.4) | 67 (45.6) |
| Level of education, | ||||
| Low | 153 (28.9) | 85 (34.3) | 35 (25.7) | 33 (22.6) |
| Intermediate | 228 (43.0) | 102 (41.1) | 58 (42.6) | 68 (46.6) |
| High | 149 (28.1) | 61 (24.6) | 43 (31.6) | 45 (30.8) |
| Duration of diabetes, years (mean, SD) | 13.3 (8.07) | 13.6 (8.44) | 14.1 (8.02) | 12.1 (7.19) |
| Diabetes treatment | ||||
| Lifestyle advise only | 65 (12.3) | 30 (12.1) | 21 (15.4) | 14 (9.6) |
| Oral antihyperglycaemic therapy only | 339 (64.1) | 165 (66.8) | 83 (61.0) | 91 (62.3) |
| Insulin ± oral antihyperglycaemic therapy | 125 (23.6) | 52 (21.2) | 32 (23.5) | 41 (28.1) |
| Chronic co‐morbidity ( | ||||
| No co‐morbidity | 86 (16.0) | 41 (16.3) | 11 (8.0) | 34 (23.1) |
| 1–2 co‐morbidities | 269 (50.2) | 138 (54.8) | 64 (46.7) | 67 (45.6) |
| >3 co‐morbidities | 181 (33.8) | 73 (29.0) | 62 (45.3) | 46 (31.3) |
| Of which | ||||
| Ischaemic heart/ artery disease or cardiac failure | 103 (19.2) | 50 (19.8) | 33 (24.1) | 20 (13.6) |
| Asthma or COPD | 77 (14.4) | 28 (11.1) | 19 (13.9) | 30 (20.4) |
| Diabetic complication | 110 (20.5) | 51 (20.2) | 37 (27.0) | 22 (15.0) |
| COVID−19 complaints during lockdown ( | ||||
| Yes, tested positive | 4 (0.7) | 1 (0.4) | 1 (0.7) | 2 (1.4) |
| Yes, but tested negative | 2 (0.4) | 0 | 2 (1.5) | 0 |
| Yes, but not tested | 51 (9.5) | 19 (7.5) | 19 (13.9) | 13 (8.8) |
| No | 461 (86.0) | 222 (88.1) | 112 (81.8) | 127 (86.4) |
| I don't know | 18 (3.4) | 10 (4.0) | 3 (2.2) | 5 (3.4) |
| Meets fit norm | 299 (56.4) | 137 (54.6) | 71 (52.6) | 91 (63.2) |
| Minutes moderate‐vigorous intensity physical activity per week | 420 (626.3) | 395 (696.8) | 345 (515.0) | 485 (625.0) |
Co‐morbidities pre‐defined in the following groups: COPD, obesity, ischaemic vascular disease, heart failure, asthma, dyslipidaemia, hypertension, rheumatic disease, arthrosis, kidney failure, polyneuropathy, diabetic ulcer, retinopathy, depression, ‘other’.
Diabetes complication: retinopathy, nephropathy, polyneuropathy and/or diabetic foot ulcer.
> 150 min moderate—vigorous physical activity per week.
Perceived stress score, perceived change in stress, anxiety for and perceived risk of infection, emotional well‐being, per change in PA group in people with type 2 diabetes during COVID‐19 societal lockdown
|
Total ( |
No change in PA ( |
Less active ( |
More active ( | |
|---|---|---|---|---|
| Perceived change in stress | ||||
| More stress | 153 (29.1) | 47 (19.1) | 59 (43.4) | 47 (32.9) |
| Less stress | 63 (12.0) | 21 (8.5) | 22 (16.2) | 20 (14.0) |
| No change in stress | 309 (58.9) | 178 (72.4) | 55 (40.4) | 76 (53.1) |
| Perceived Stress Score (mean, SD) | 12.98 (6.61) | 11.69 (5.95) | 15.21 (6.90) | 13.11 (6.89) |
| WHO well‐being index score (mean, SD) | 64.9 (23.9) | 70.2 (21.6) | 53.5 (25.8) | 66.7 (22.4) |
| Anxiety for infection (median, IQR) | 4.2 (2.5) | 3.9 (2.4) | 4.7 (2.5) | 4.2 (2.5) |
| Perceived risk of infection (mean, SD) | 2.9 (0.8) | 2.8 (0.9) | 3.0 (0.7) | 2.9 (0.8) |
The p‐values represent the comparison between the change in PA groups, using chi‐square tests for categorical variables against a Bonferroni‐adjusted alpha of .0056 (.05/9) and ANOVA's for continuous variables against a Bonferroni‐adjusted alpha of .017 (.05/3).
Significantly different from increase and decrease in PA group p < .0001.
Significantly different from increase and decrease in PA group p < .0001.
Significantly different from unchanged PA group (p < .0001) and increase in PA group (p = .007).
Significantly different from unchanged PA group and increase in PA group (p < .0001).
Significantly different from unchanged PA group on anxiety for infection (p = .001) and perceived risk of infection (p = .003).
Multivariate multinomial regression model on the factors associated with change in PA in people with type 2 diabetes during COVID‐19 societal lockdown
| Factors | Less active versus no change in PA | More active versus no change in PA | ||||
|---|---|---|---|---|---|---|
| OR | 95% CI |
| OR | 95% CI |
| |
| Sex (male) | 0.69 | 0.43 to 1.12 | .135 | 0.55 | 0.34 to 0.88 | .012 |
| Age | 0.99 | 0.96 to 1.03 | .699 | 0.94 | 0.92 to 0.97 | <.0001 |
| Level of education | ||||||
| Low | 0.51 | 0.27 to 0.95 | .033 | 0.45 | 0.24 to 0.84 | .012 |
| Middle | 0.74 | 0.43 to 1.29 | .284 | 0.89 | 0.52 to 1.53 | .683 |
| High | Ref | Ref | ||||
| Diabetes treatment | ||||||
| Lifestyle only | 1.37 | 0.63 to 2.97 | .430 | 0.60 | 0.26 to 1.36 | .219 |
| Oral antihyperglycaemic therapy only | 0.90 | 0.51 to 1.60 | .728 | 0.71 | 0.42 to 1.21 | .210 |
| Insulin ± oral antihyperglycaemic therapy | Ref | Ref | ||||
| Number of co‐morbidities | ||||||
| None | 0.46 | 0.21 to 1.02 | .055 | 1.40 | 0.73 to 2.70 | .310 |
| 1–2 | 0.64 | 0.38 to 1.05 | .079 | 0.70 | 0.41 to 1.18 | .181 |
| ≥3 | Ref | Ref | ||||
| Former PA status: compliance to fit norm (yes) | 1.07 | 0.67 to 1.71 | .782 | 1.57 | 0.99 to 2.50 | .056 |
| Perceived change in stress | ||||||
| More stress | 2.27 | 1.25 to 4.13 | .007 | 2.31 | 1.25 to 4.26 | .007 |
| Less stress | 2.20 | 1.03 to 4.71 | .042 | 1.78 | 0.82 to 3.85 | .143 |
| No change in stress | Ref | Ref | ||||
| Anxiety | 0.99 | 0.89 to 1.11 | .899 | 0.96 | 0.86 to 1.07 | .483 |
| Perceived risk of infection | 1.18 | 0.86 to 1.61 | .317 | 1.07 | 0.78 to 1.45 | .685 |
| Emotional well‐being | 0.98 | 0.97 to 0.99 | <.001 | 1.01 | 0.99 to 1.02 | .230 |
Reference group = no change in PA. The final model is a significant improvement in fit over a null model. −2Log‐likelihood: final model: 951.9 vs null model: 1070.7 (X2(28) = 118.8, p < .001). Pearson's chi‐square: X2(980) = 1002.42, p =0.302; deviance chi‐square: X2(980) = 951.91, p = .734.
Abbreviations: CI, confidence interval; OR, adjusted odds ratio; Ref, reference category of the factor.
p < .05.
p < .01